Feilkilder ved bruk av hemoglobin A1c

Tidsskrift for den Norske Laegeforening

Volumn 134, Issue 4, 2014, Pages 417-421

  Vikøren, Thea Berge ^a,b   Berg, Jens Petter ^a,b   Berg, Tore Julsrud ^a,c  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN;

ARTICLE; BLOOD; BLOOD ANALYSIS; DIABETES MELLITUS; ETHNOLOGY; GLUCOSE BLOOD LEVEL; HUMAN; METABOLISM; STANDARD;

BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; BLOOD GLUCOSE; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS;

EID: 84897723132     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.13.0938     Document Type: Article

References (41)

1. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-34.
2. Reseptregisteret. http://reseptregisteret.no/Prevalens.aspx (17.7.2013).
3. Claudi T, Ingskog W, Cooper JG et al. Kvaliteten på diabetesbehandlingen i allmennpraksis. Tidsskr Nor Legeforen 2008; 128: 2570-4.
4. 1csom diagnostikum for diabetes. Oslo: Helsedirektoratet, 2012.
5. Oppenheimer M, Jensen R, Huntington MK. When 7 isn't 7: glycohemoglobin and chronic kidney disease. S D Med 2013; 66: 59-61.
6. Sacks DB, Arnold M, Bakris GL et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011; 57: e1-47.
7. Tsugawa Y, Mukamal KJ, Davis RB et al. Should the hemoglobin A(1c) diagnostic cutoffdiffer between blacks and whites?: a cross-sectional study. Ann Intern Med 2012; 157: 153-9.
8. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
9. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
10. Nasjonale faglige retningslinjer. Diabetes. Forebygging, diagnostikk og behandling. Oslo: Helsedirketoratet, 2009.
11. Nathan DM, Kuenen J, Borg R et al. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008; 31: 1473-8.
12. Ealovega MW, Tabaei BP, Brandle M et al. Opportunistic screening for diabetes in routine clinical practice. Diabetes Care 2004; 27: 9-12.
13. Gallagher EJ, Le Roith D, Bloomgarden Z. Review of hemoglobin A(1c) in the management of diabetes. J Diabetes 2009; 1: 9-17.
14. Kilpatrick ES, Maylor PW, Keevil BG. Biological variation of glycated hemoglobin. Implications for diabetes screening and monitoring. Diabetes Care 1998; 21: 261-4.
15. Hare MJ, Shaw JE, Zimmet PZ. Current controversies in the use of haemoglobin A1c. J Intern Med 2012; 271: 227-36.
16. Soranzo N. Genetic determinants of variability in glycated hemoglobin (HbA(1c)) in humans: review of recent progress and prospects for use in diabetes care. Curr Diab Rep 2011; 11: 562-9.
17. Snieder H, Sawtell PA, Ross L et al. HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes 2001; 50: 2858-63.
18. Hempe JM, Gomez R, McCarter RJ Jr et al. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications 2002; 16: 313-20.
19. Pani LN, Korenda L, Meigs JB et al. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 2008; 31: 1991-6.
20. Ziemer DC, Kolm P, Weintraub WS et al. Glucoseindependent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med 2010; 152: 770-7.
21. Saaddine JB, Fagot-Campagna A, Rolka D et al. Distribution of HbA(1c) levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey. Diabetes Care 2002; 25: 1326-30.
22. Herman WH, Cohen RM. Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes. J Clin Endocrinol Metab 2012; 97: 1067-72.
23. Boltri JM, Okosun IS, Davis-Smith M et al. Hemoglobin A1c levels in diagnosed and undiagnosed black, Hispanic, and white persons with diabetes: results from NHANES 1999-2000. Ethn Dis 2005; 15: 562-7.
24. Heisler M, Faul JD, Hayward RA et al. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med 2007; 167: 1853-60.
25. Adams AS, Trinacty CM, Zhang F et al. Medication adherence and racial differences in A1C control. Diabetes Care 2008; 31: 916-21.
26. Brun A, Gaudernack G, Sandberg S. A new method for isolation of reticulocytes: positive selection of human reticulocytes by immunomagnetic separation. Blood 1990; 76: 2397-2403.
27. de Jager J, Kooy A, Lehert P et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ 2010; 340: c2181.
28. Koga M, Kasayama S, Kanehara H et al. CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases. Diabetes Res Clin Pract 2008; 81: 258-62.
29. Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol 2004; 112: 126-8.
30. Proto G, De Marchi S, Cecchin E. Glycosylated hemoglobin in chronic alcoholics. Drug Alcohol Depend 1983; 12: 299-302.
31. Hardikar PS, Joshi SM, Bhat DS et al. Spuriously high prevalence of prediabetes diagnosed by HbA(1c) in young indians partly explained by hematological factors and iron deficiency anemia. Diabetes Care 2012; 35: 797-802.
32. Roszyk L, Faye B, Sapin V et al. Glycated haemoglobin (HbA1c): today and tomorrow. Ann Endocrinol (Paris) 2007; 68: 357-65.
33. Lilleholt K, Hallberg MH, Hagve TA. Hemoglobinopatier og fremmedartede navn. Tidsskr Nor Lægeforen 2005; 125: 1164-7.
34. Behan KJ, Merschen J. HbA1c does not always estimate average glucose. Clin Lab Sci 2011; 24: 71-7.
35. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 2001; 47: 153-63.
36. American Diabetes Association. Standards of medical care in diabetes - 2010. Diabetes Care 2010; 33 (suppl 1): S11-61.
37. Zheng CM, Ma WY, Wu CC et al. Glycated albumin in diabetic patients with chronic kidney disease. Clin Chim Acta 2012; 413: 1555-61.
38. Koga M, Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocr J 2010; 57: 751-62.
39. Mosca A, Paleari R, Dalfrà MG et al. Reference intervals for hemoglobin A1c in pregnant women: data from an Italian multicenter study. Clin Chem 2006; 52: 1138-43.
40. Makris K, Spanou L. Is there a relationship between mean blood glucose and glycated hemoglobin? J Diabetes Sci Technol 2011; 5: 1572-83.
41. Hashimoto K, Osugi T, Noguchi S et al. A1C but not serum glycated albumin is elevated because of iron deficiency in late pregnancy in diabetic women. Diabetes Care 2010; 33: 509-11.